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Pericyclic rearrangements of N-heterocyclic carbenes of
indazole to substituted 9-aminoacridines†
Zong Guan, Sascha Wiechmann, Martin Drafz, Eike Hübner and Andreas Schmidt*
On deprotonation, 1-arylindazolium salts form 1-arylindazol-3-ylidenes which rearrange spontaneously
via ring cleavage, ring closure and subsequent proton transfer to substituted 9-aminoacridines. By con-
trast, the N-heterocyclic carbene of 2-phenylindazolium cannot rearrange similarly and was trapped by
sulfur.
Introduction
Acridines display a broad variety of biological activities. Thus
the antimalarial Mepacrine1 (Atebrin) was described nearly
80 years ago.2 Other medicinal and pharmaceutical appli-
cations cover the range from antitumor compounds (Nitra-
crine,3 Amsacrine4), germicides (Proflavine5), to antiseptic
agents (Ethacridine6). It is well known that acridines are DNA
intercalators and so they have been used as building elements
in intercalator peptides.7 Tacrine8 was approved for the treat-
ment of Alzheimer’s disease. Some other acridines have been
prepared and used as dyes, fluorescent compounds and struc-
ture elements of new materials.9
The chemistry of acridines has been the subject of several
books10 and reviews.11 As substitution reactions often result in
mixtures of regioisomers, the most widely applied syntheses of
acridines are those involving ring closure reactions, often fol-
lowed by aromatizations. At least six classes of ring closure
reactions to acridines can be recognized10 which are character-
ized in Fig. 1.
The condensation of 2-aminophenylcarbonyl compounds
with phenols13 (von Niementowski reaction12) belongs to class
I of ring closure reactions and the same is true for the reaction
of isatins and phenols.14 The reaction of 2-aminobenzaldehyde
1 with phloroglucinol to give 1,3-dihydroxyacridine 7a is pre-
sented as an example13 (Scheme 1). This reaction, however,
seems to be of rather limited applicability as some phenols do
not react under these conditions. Often strongly basic con-
ditions have to be applied which cause some substituent
incompatibilities.10 The modified Friedländer reaction gives
di- or tetrahydroacridines which can be oxidized sub-
sequently.15 Catalysts have been examined in this reaction.16
2-Haloacylbenzenes react readily with anilines to aﬀord
9-substituted acridines. This reaction, which represents a ring
closure of type II, is known as Ullmann synthesis.10 The treat-
ment of 2 with aniline to give 2-nitro-9-phenylacridine 7b17 is
shown in Scheme 1. Acridines are also formed on reaction of
benzyne with diimines.18 The Bernthsen reaction belongs to
class III of acridine syntheses. This reaction starts from diphe-
nylamines and a one-carbon donor such as carboxylic acids or
dicarboxylic acids.19 As shown in Scheme 1, diphenylamine 3
gives 7c. The Bernthsen reaction, however, proceeds under vig-
orous conditions which cause considerably diminished yields.
Class IV is represented by the cyclization of bis(aminoaryl)-
methanes such as 4 to 7d.20 In the presence of calcium oxide,
acridine is formed in 75% yield; however, a temperature of
600 °C over a period of 40 minutes is necessary.21 The cycliza-
tion of 2-(arylamino)benzaldehydes,22 available by McFayden–
Stevens reaction,23 or (2-arylamino)acetophenones24 represents
class V of ring closure reactions to acridines. Indium triflate
catalysts have been tested.25 The reaction of 5 with 7e is repre-
sentative of this class of ring closure reactions. Class VI is
exemplified by the silver-26 or rhodium-catalyzed27 cyclisation
of 3-oxo-3-(2-ethynylquinolin-3-yl)propanoates (cf. 6 to 7f ). A
very limited number of acridine syntheses involving ring trans-
formations has been described, among which is the photolysis
Fig. 1 Six categories of ring closure reactions to form acridines.
†Electronic supplementary information (ESI) available: Theoretical details. See
DOI: 10.1039/c3ob40379c
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of suitably substituted benzotriazoles28 or the ring contraction
of dibenzazepines.29 Either transformation is of limited
applicability.
During the last decade, interest in N-heterocyclic carbenes
(NHC) has been high. New NHC structures,30 eﬀective NHC
ligands in metal-catalyzed reactions,31 or NHC organocata-
lysts32 have been developed and applied very successfully. Less
attention has been focused on N-heterocyclic carbenes as the
starting materials or reactive intermediates in heterocyclic syn-
thesis. Recently, we described a 4-aminoquinoline synthesis
via pyrazole-3-ylidenes.33 To the best of our knowledge, the
N-heterocyclic carbene of indazole has been prepared for the
first time by decarboxylation of the pseudo-cross-conjugated
heterocyclic mesomeric betaine (PCCMB)34 indazolium-3-car-
boxylate35 (Scheme 2). An alternative approach to indazol-3-
ylidene is deprotonation of indazolium salts. In the case where
R1 ≠ Ar, indazole-3-ylidene can be used as a reagent or as a
building block in synthesis,36 and in coordination chemistry.37
We report here a rearrangement reaction for the synthesis
of substituted acridines from indazolium salts which possess a
phenyl ring in position 1 (R1 = Ar). This rearrangement pro-
ceeds via the N-heterocyclic carbene of indazole. We examined
the scope and limitations of this ring transformation and per-
formed DFT-calculations to gain insight into the mechanism.
Results and discussion
Suitable indazole derivatives have been prepared by two
diﬀerent methods (Scheme 3). As method A, a Buchwald–
Hartwig coupling of 2-bromobenzaldehyde hydrazones 8 with
Pd(dba)2 in the presence of rac-BINAP and potassium phos-
phate according to a modified literature procedure38 has been
applied. Method B, which proved to give slightly better yields
in all the compared cases, is a copper(I)-catalyzed coupling of
indazoles 9a,b and iodobenzenes 10a–h using CuI, 1,2-diamino-
cyclohexane, and potassium phosphate in dioxane. Thus,
method A gave 85% of 1-phenylindazole 11a (Table 1, entry 1),
whereas method B gave 91% (Table 1, entry 4). Method A was
employed for the synthesis of the indazoles 11b,c in good
yields, whereas method B was used to prepare 11d–h in moder-
ate to almost quantitative yields. The indazoles 11c,39 11f,38
and 11g40 have been described before.
The indazoles 11i and 11j were synthesized from 11e, which
was subjected to a Suzuki–Miyaura coupling reaction
(Scheme 4 and Table 1, entries 11 and 12, method B + S). The
latter mentioned reaction was performed applying a cyclobu-
tene-bis-imidazol-3-ylidene ligand which we described
earlier.41
Dimethylsulfate or diethylsulfate in boiling toluene and a
subsequent anion exchange converted the 1-arylindazoles into
the new indazolium salts 12a–k as pure crystalline compounds
in high yields (Table 1, entries 1–3, 5–12) (Scheme 5).
Scheme 1
Scheme 2 Scheme 3
Organic & Biomolecular Chemistry Paper
This journal is © The Royal Society of Chemistry 2013 Org. Biomol. Chem., 2013, 11, 3558–3567 | 3559
Pu
bl
ish
ed
 o
n 
08
 A
pr
il 
20
13
. D
ow
nl
oa
de
d 
by
 T
ec
hn
isc
he
 U
ni
ve
rs
ita
et
 C
la
us
th
al
 o
n 
12
/0
8/
20
14
 1
3:
48
:4
3.
 
View Article Online
The indazolium salts 12a–k were then used to perform the
title indazole→acridine rearrangements. Heating 1-phenyl-
indazolium salt 12a with K3PO4 in anhydrous dioxane over a
period of three hours gave the N-methyl-9-acridinylamine 13a
in 87% isolated yield (Table 2, entry 1). These conditions were
also applied to prepare the acridinylamines 13b–k (Table 2,
entries 2–11). As expected, the rearrangement of the indazo-
lium salt 12b resulted in the formation of two regioisomeric
products in 70% overall yield, 13b and 13c, which we separated
by column chromatography (Table 2, entries 2a,b). The acridi-
nylamines 13ba, 13c, 13e, 13f–h, 13j,k are new compounds.
The parent compound of the series 13a has of course been
synthesized before by various methods. Among those, the reac-
tion of 9-chloroacridine with methylamine seems to be the
most eﬀective one (91% yield42). Likewise, 13i was obtained
with ethylamine in 87% yield.42 The acridines 13bb and 13c
have been mentioned before; however, experimental details
are not available (Scheme 6).43
According to a DFT-calculation the rearrangement of 12a
proceeds via indazol-3-ylidene 12A, which is formed on depro-
tonation of the indazolium salts (Scheme 7). Prominent peaks
of the carbene 12A are visible at m/z = 417.1 [12a·12A]+ in the
ESI mass spectra between 0 and 50 V fragmentor voltage on
spraying a sample of 12a from a methanol solution of Li2CO3.
The silver adduct [12A·Ag·12A]+ can be detected at m/z = 523.1
on the addition of AgOAc to the same solution. Ring opening
of the pyrazole moiety by cleavage of the N–N bond to 12B
(ΔG# = +18.4 kJ mol−1; ΔG = −76.1 kJ mol−1), followed by
trans–cis isomerisation of the phenylimine group (ΔG# =
+65.6 kJ mol−1; ΔG = −60.4 kJ mol−1), 6π-electrocyclic ring
closure to 12C (ΔG# = +55.1 kJ mol−1; ΔG = −107 kJ mol−1) and
subsequent proton transfer yielded the 9-aminoacridine 13a.
The proton transfer must proceed intermolecularly, as an
intramolecular process has an activation barrier of ΔG# =
+165.4 kJ mol−1 according to the calculation.
We also calculated bond lengths and partial charges of the
intermediate 12B which is shown in Fig. 2. The calculation pre-
dicts a CvC double bond (1.353 Å) as well as a CvN double
bond (1.201 Å) in 12B which are slightly longer and shorter,
respectively, in comparison with the calculated values of N-
vinylidenemethanamine 14 (CvC: 1.316 Å; CvN: 1.224 Å) as
model substance. The ketimine resonance structure of 12B is
also reflected in the bond lengths of the former benzene ring
and the exocyclic imine moiety (1.298 Å). These data suggest
that the ring closure is predominantly pericyclic in nature,
similar to the pyrazole-3-ylidene→quinoline rearrangement
which we described before.33
We next prepared the isomer of 12a, i.e. the 1-methyl-2-phe-
nylindazolium salt 17 (Scheme 8). Arylation of indazole with
2-(trimethylsilyl)phenyl trifluoromethanesulfonate 15 in the
presence of a mixture of CsF and NaF in MeCN gave 2-pheny-
lindazole 16.44 We methylated 16 to 17 which was obtained in
66% yield over two steps after anion exchange with
Table 1 Preparation of indazoles 11a–j and indazolium salts 12a–k
Entry R1 R2 R3 R4 R5 R6 Method Yield (%) Yield (%)
1 H H H H H Me A 85 (11a) 91 (12a)
2 Cl H H H H Me A 67 (11b) 84 (12b)
3 H H H Cl H Me A 79 (11c) 91 (12c)
4 H H H H H Me B 91 (11a) /
5 H I H H Br Me B 54 (11d) 94 (12d)
6 H I H H H Me B 40 (11e) 87 (12e)
7 H CF3 H H H Me B 82 (11f) 83 (12f)
8 Me H Me H H Me B 96 (11g) 88 (12g)
9 H H H H Br Me B 64 (11h) 75 (12h)
10 H H H H H Et B / 77 (12i)
11 H Ph H H H Me B + S 83 (11i) 72 (12j)
12 H 3-Tolyl H H H Me B + S 95 (11j) 58 (12k)
Scheme 4
Scheme 5
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tetraphenylborate. Deprotonation of 17 with KOtBu in 1,4-
dioxane gave the indazolium-3-ylidene 17A, which cannot
rearrange according to the mechanism described above. As a
consequence, we were able to trap 17A with sulfur to the inda-
zole-3-thione 18 in moderate yield.
Conclusions
In summary we present a new synthesis for new acridines via a
rearrangement of in situ generated indazol-3-ylidenes.
Experimental
General considerations
Dioxane was dried over sodium according to standard pro-
cedures before usage. All reactions for the palladium-catalyzed
intramolecular amination and the rearrangement were carried
out under an atmosphere of nitrogen in oven-dried glassware.
Flash-chromatography was performed with silica gel 60
(0.040–0.063 mm). Nuclear magnetic resonance (NMR) spectra
were obtained with a Bruker Avance 400 MHz and Bruker
Avance III 600 MHz. 1H NMR spectra were recorded at
400 MHz or 600 MHz. 13C NMR spectra were recorded at
100 MHz or 150 MHz, with the solvent peak or tetramethyl-
silane used as the internal reference. Multiplicities are described
by using the following abbreviations: s = singlet, d = doublet,
t = triplet, q = quartet, and m = multiplet. FT-IR spectra were
obtained on a Bruker Alpha T equipped with a Platinum ATR
unit. The mass spectra were measured with a Varian 320 MS
Triple Quad GC/MS/MS with a Varian 450-GC. The electrospray
ionization mass spectra (ESI-MS) were measured with an
Agilent LCMSD series HP 1100 with APIES. Melting points are
uncorrected and were determined in an apparatus according
to Dr Tottoli (Büchi). Yields are not optimized. Compounds
8a,38 11a,38 11c,39 11f,38 and 11g40 were prepared as described
in the literature.
2-Bromobenzaldehyde 3-chlorophenylhydrazone 8b. A solu-
tion of 185 mg (1.0 mmol) of 2-bromobenzaldehyde in 5 mL of
methanol was added to a hot solution of 142 mg (1 mmol) of
3-chlorophenylhydrazine in 1 mL of methanol. The mixture
was stirred with reflux temperature for 30 minutes. After
cooling to −30 °C and keeping this temperature for 12 h, the
precipitate was collected by filtration, washed twice with
0.5 mL of cold methanol and dried in vacuo. Yield: 209 mg
(68%) of a white solid, m.p. 144 °C. 1H NMR (600 MHz,
DMSO-d6): δ = 10.94 (s, 1H), 8.19 (s, 1H), 8.01 (dd, J = 8.0/
1.7 Hz, 1H), 7.62 (dd, J = 8.0/1.1 Hz, 1H), 7.42–7.39 (m, 1H),
7.25–7.22 (m, 2H), 7.13 (t, J = 2.0 Hz, 1H), 6.99 (ddd, J = 8.0/
2.0/0.8 Hz, 1H), 6.80 (ddd, J = 8.0/2.0/0.8 Hz, 1H) ppm. 13C
NMR (150 MHz, DMSO-d6): δ = 146.3, 135.8, 133.9, 133.8,
132.9, 130.8, 129.9, 127.9, 126.4, 121.9, 118.7, 111.4,
110.9 ppm; IR (KBr): 3316, 2977, 2938, 1590, 1517, 1468, 1436,
Table 2 Rearrangement of indazolium salts 12a–k to acridines 13a–k
Entry R1 R2 R3 R4 R7 R9 Starting material Solvent Yield (%)
1 H H H H H NHMe 12a Dioxane 87 (13a)
2a Cl H H H H NHMe 12b Toluene 30 (13ba)
2b H H Cl H H NHMe 12b Toluene 40 (13bb)
3 H H H Cl H NHMe 12c Dioxane 83 (13c)
4 H I H H Br NHMe 12d Dioxane 35 (13d)
5 H I H H H NHMe 12e Dioxane 41 (13e)
6 H CF3 H H H NHMe 12f Dioxane 51 (13f)
7 Me H Me H H NHMe 12g Dioxane 58 (13g)
8 H H H H Br NHMe 12h Dioxane 32 (13h)
9 H H H H H NHEt 12i Toluene 60 (13i)
10 H Ph H H H NHMe 12j Toluene 83 (13j)
11 H 3-Tolyl H H H NHMe 12k Toluene 37 (13k)
Scheme 6
Scheme 7
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1261, 1142, 755, 680, 671, 441 cm−1. MS (70 eV): m/z = 308
[M+]. HR-ESI-MS for C13H11N2BrCl required 308.9794. Found:
308.9797.
2-Bromobenzaldehyde 2-chlorophenylhydrazone 8c. A solu-
tion of 185 mg (1.0 mmol) of 2-bromobenzaldehyde in 5 mL of
methanol was added to a hot solution of 142 mg (1 mmol) of
2-chlorophenylhydrazine in 1 mL of methanol. The mixture
was stirred with reflux temperature for 30 min. After cooling to
−30 °C and keeping this temperature for 12 h, the precipitate
was collected by filtration, washed twice with 0.5 mL of cold
methanol and dried in vacuo. Yield: 262 mg (85%) of a white
solid, m.p. 120 °C. 1H NMR (400 MHz, DMSO-d6): δ = 10.38 (s,
1H), 8.64 (s, 1H), 8.03 (dd, J = 8.0/1.5 Hz, 1H), 7.64 (dd, J = 8.0/
1.1 Hz, 1H), 7.59 (dd, J = 8.3/1.5 Hz, 1H), 7.41 (dd, J = 8.0/7.5
Hz, 1H), 7.34 (dd, J = 8.0/1.5 Hz, 1H), 7.29–7.24 (m, 2H), 6.82
(ddd, J = 8.0/7.5/1.5 Hz, 1H) ppm. 13C NMR (100 MHz, DMSO-
d6): δ = 141.1, 138.3, 134.2, 133.0, 130.0, 129.4, 128.0, 127.9,
126.5, 122.3, 120.1, 116.4, 114.2 ppm; IR (ATR): 3318, 1552,
1455, 1270, 1215, 1047, 1031, 949, 735, 708, 680, 440 cm−1. MS
(70 eV): m/z = 308 [M+]. HR-ESI-MS for C13H11N2BrCl required
308.9794. Found: 308.9797.
General procedure for the preparation of 1-aryl-1H-indazoles
by intramolecular palladium-catalysed cross-coupling
(method A)
1.0 mmol of the 2-bromobenzaldehyde arylhydrazones,
424 mg (2.0 mmol) of K3PO4, 11 mg (0.02 mmol) of rac-BINAP,
12 mg (0.02 mmol) of Pd(dba)2 and 10 mL of anhydrous
toluene were stirred at reflux temperature under an atmos-
phere of nitrogen for 12 hours. The resulting mixture was then
cooled to room temperature and evaporated to dryness. The
crude products were purified by flash column chromatography
(petroleum ether–ethyl acetate = 3 : 1).
1-(3-Chlorophenyl)-1H-indazole 11b. Yield: 153 mg (67%) of
a colorless oil. 1H NMR (400 MHz, DMSO-d6): δ = 8.42 (s, 1H),
7.92–7.87 (m, 2H), 7.82–7.78 (m, 2H), 7.61 (t, J = 8.0 Hz, 1H),
7.52 (dd, J = 8.0/7.2 Hz, 1H), 7.47–7.44 (m, 1H), 7.29 (dd, J =
8.0/7.2 Hz, 1H) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 140.9,
138.0, 136.4, 133.9, 131.3, 127.8, 126.2, 125.2, 122.0, 121.6,
121.5, 120.2, 110.5 ppm; IR (NaCl): 3067, 1594, 1485, 1371,
1259 cm−1. MS (70 eV): m/z = 228 [M+]. HR-ESI-MS: C13H10N2Cl
required 229.0533. Found: 229.0533.
General procedure for the preparation of 1-aryl-1H-indazoles
by intermolecular copper(I)-coupling (method B)
A mixture of 1.0 mmol of 1H-indazole, 1.2 mmol of aryliodide,
19 mg (0.1 mmol) of copper(I) iodide, 0.01 mL (0.1 mmol) of
(R,S)-1,2-diaminocyclohexane, 424 mg (2.0 mmol) of K3PO4
in 10 mL of 1,4-dioxane was stirred at reflux temperature for
24 h. The resulting mixture was then cooled to room temp-
erature and evaporated to dryness. The crude product was
purified by flash column chromatography (petroleum ether–
ethyl acetate = 2 : 1).
5-Bromo-1-(4-iodophenyl)-1H-indazole 11d. Yield: 215 mg
(54%) of colorless crystals, m.p. 129 °C. 1H NMR (400 MHz,
CDCl3): δ = 8.13 (d, J = 0.4 Hz, 1H), 7.93 (d, J = 1.8 Hz, 1H),
7.87–7.83 (m, 2H), 7.58 (d, J = 9.0 Hz, 1H), 7.50 (dd, J = 9.0/1.8
Hz, 1H), 7.47–7.44 (m, 2H) ppm; 13C NMR (100 MHz, CDCl3):
δ = 139.5, 138.6, 137.3, 135.0, 130.5, 127.1, 124.3, 123.9, 114.8,
111.7, 91.4 ppm; IR (KBr): 3061, 2360, 1585, 1494, 1439, 1416,
1183, 1058, 979, 821, 795, 785 cm−1. ESI-MS (100 V, HCl):
m/z = 399 [M + H+]. HR-ESI-MS: C13H9N2BrI required 398.8994.
Found: 398.8994.
1-(4-Iodophenyl)-1H-indazole 11e. Yield: 129 mg (40%) of
colorless crystals, m.p. 100 °C. 1H NMR (400 MHz, CDCl3): δ =
8.20 (d, J = 0.7 Hz, 1H), 7.86–7.83 (m, 2H), 7.80 (dt, J = 8.0/
0.9 Hz, 1H), 7.72 (dd, J = 8.6/0.9 Hz, 1H), 7.53–7.49 (m, 2H),
7.46–7.42 (m, 1H), 7.26–7.22 (m, 1H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 140.0, 138.6, 138.5, 136.0, 127.5, 125.6, 124.3,
121.8, 121.5, 110.3, 90.8 ppm; IR (KBr): 3055, 1612, 1585,
1489, 1418, 1211, 979, 819, 749 cm−1. MS (70 eV): m/z =
320 [M+]. HR-ESI-MS: C13H10N2I required 320.9889. Found:
320.9893.
5-Bromo-1-phenyl-1H-indazole 11h. Yield: 175 mg (64%) of
colorless crystals, m.p. 113 °C. 1H NMR (400 MHz, CDCl3): δ =
8.14 (d, J = 0.8 Hz, 1H), 7.94 (dd, J = 1.8/0.5 Hz, 1H), 7.70–7.67
(m, 2H), 7.62 (dt, J = 8.9/0.6 Hz, 1H), 7.57–7.53 (m, 2H), 7.49
Fig. 2 Results of calculations.
Scheme 8
Paper Organic & Biomolecular Chemistry
3562 | Org. Biomol. Chem., 2013, 11, 3558–3567 This journal is © The Royal Society of Chemistry 2013
Pu
bl
ish
ed
 o
n 
08
 A
pr
il 
20
13
. D
ow
nl
oa
de
d 
by
 T
ec
hn
isc
he
 U
ni
ve
rs
ita
et
 C
la
us
th
al
 o
n 
12
/0
8/
20
14
 1
3:
48
:4
3.
 
View Article Online
(dd, J = 8.9/1.8 Hz, 1H), 7.41–7.37 (m, 1H) ppm. 13C NMR
(100 MHz, CDCl3): δ = 139.9, 137.6, 134.6, 130.3, 129.7, 127.2,
127.0, 123.9, 122.9, 114.6, 112.0 ppm; IR (KBr): 3057, 1599,
1500, 1486, 1183, 980, 908, 811, 784, 760, 727, 695 cm−1.
ESI-MS (100 V, HCl): m/z = 273 [M + H+]. HR-ESI-MS for
C13H10N2Br required 273.0027. Found: 273.0027.
General procedure for the preparation of 1-aryl-1H-indazoles
by Suzuki-coupling
A mixture of 1.0 mmol of 1-(4-iodophenyl)-1H-indazole (11e),
1.2 mmol of the corresponding boronic acid, 42 mg
(0.05 mmol) of a 1 : 1 mixture of Pd(OAC)2 and (cyclobutene-
1,2-diyl)bis-imidazolium tetrafluoroborate, and 530 mg
(2.5 mmol) of K3PO4 in 20 mL of toluene was stirred at reflux
temperature for 8 h. The resulting mixture was then cooled to
room temperature and evaporated to dryness. The crude
product was purified by flash column chromatography (pet-
roleum ether–ethyl acetate = 3 : 1).
1-([1,1′-Biphenyl]-4-yl)-1H-indazole 11i. Yield: 223 mg (83%)
of a white solid, m.p. 163 °C. 1H NMR (400 MHz, CDCl3): δ =
8.23 (d, J = 0.8 Hz, 1H), 7.83–7.80 (m, 4H), 7.78–7.75 (m, 2H),
7.67–7.64 (m, 2H), 7.50–7.43 (m, 3H), 7.40–7.36 (m, 1H),
7.26–7.22 (m, 1H) ppm. 13C NMR (100 MHz, CDCl3): δ = 140.3,
139.5, 139.4, 138.8, 135.6, 128.9, 128.1, 127.6, 127.3, 127.1,
125.4, 122.9, 121.6, 121.4, 110.5 ppm. IR (ATR): 3038, 2923,
2363, 2134, 1949, 1656, 1602, 1527, 1463, 1380, 1219, 1185,
1147, 1071, 1017, 948, 837, 753, 690 cm−1. MS (70 eV): m/z =
270.1 [M+]. HR-ESI-MS: C19H15N2 required 271.1235. Found:
271.1233.
1-(3′-Methyl-[1,1′-biphenyl]-4-yl)-1H-indazole 11j. Yield:
270 mg (95%) of a white solid, m.p. 85 °C. 1H NMR (400 MHz,
CDCl3): δ = 8.20 (d, J = 0.6 Hz, 1H), 7.79–7.77 (m, 4H),
7.74–7.71 (m, 2H), 7.48–7.40 (m, 3H), 7.36–7.32 (m, 1H),
7.23–7.16 (m, 2H), 2.42 (s, 3H) ppm. 13C NMR (100 MHz,
CDCl3): δ = 140.3, 139.7, 139.4, 138.8, 138.6, 135.6, 128.9,
128.3, 128.2, 127.9, 127.3, 125.5, 124.2, 122.9, 121.6, 121.4,
110.6, 21.7 ppm. IR (ATR): 1604, 1520, 1494, 1488, 1464, 1419,
1377, 1353, 1199, 981, 904, 835, 750, 740, 701, 617, 585, 516,
435 cm−1. MS (70 eV): m/z = 284.1 [M+]. HR-ESI-MS: C20H17N2
required 285.1392. Found: 285.1390.
General procedure for the preparation of 2-alkyl-1-aryl-1H-
indazolium hexafluorophosphates
A solution of 1.0 mmol of 1-aryl-1H-indazole in 20 mL of
toluene was treated with 4.0 mmol of dimethylsulfate and
stirred at reflux temperature for 24 hours, during which time a
dark oil formed. After cooling to room temperature the oil was
separated from the solvent and dissolved in 20 mL of water
and filtrated. Then, a solution of 163 mg (1.0 mmol) of
ammonium hexafluorophosphate in 1 mL of water was added.
Colorless solids formed which were filtered oﬀ, recrystallized
from water, and dried in vacuo.
2-Methyl-1-phenyl-1H-indazolium hexafluorophosphate 12a.
Yield: 322 mg (91%) of colorless crystals, m.p. 118 °C. 1H NMR
(400 MHz, DMSO-d6): δ = 9.53 (s, 1H), 8.26 (d, J = 8.6 Hz, 1H),
7.81–7.89 (m, 6H), 7.59–7.63 (m, 1H), 7.38 (dd, J = 8.6/0.7 Hz,
1H), 4.16 (s, 3H) ppm. 13C NMR (100 MHz, DMSO-d6): δ =
140.7, 134.9, 134.0, 132.5, 130.8, 130.7, 129.1, 125.5, 123.4,
119.2, 110.9, 38.6 ppm. IR (KBr): 3136, 1631, 1541, 1497, 1256,
1209, 1171, 835, 766, 752 cm−1. ESI-MS (20 V): m/z = 209.1
[M+]. HR-ESI-MS: C14H14N2 required: 210.1157. Found:
210.1157.
2-Methyl-1-(3-chlorophenyl)-1H-indazolium hexafluoro-
phosphate 12b. Yield: 326 mg (84%) of colorless crystals, m.
p. 135 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.55 (s, 1H), 8.26
(d, J = 8.6 Hz, 1H), 8.06–8.05 (m, 1H), 7.95–7.92 (m, 1H),
7.89–7.83 (m, 3H), 7.63–7.59 (m, 1H), 7.46 (dd, J = 8.6/0.7 Hz,
1H), 4.18 (s, 3H) ppm. 13C NMR (100 MHz, DMSO-d6): δ =
140.7, 135.3, 134.5, 134.1, 132.6, 132.2, 131.8, 129.3, 128.2,
125.5, 123.4, 119.2, 110.9, 38.6 ppm. IR (KBr): 3129, 3111,
1631, 1590, 1537, 1504, 1459, 831, 793, 776, 761, 692,
557 cm−1. ESI-MS (0V): 243 [M+]. HR-ESI-MS: C14H13N2Cl
required 244.0767. Found: 244.0767.
1-(2-Chlorophenyl)-2-methyl-1H-indazolium hexafluoro-
phosphate 12c. Yield: 354 mg (91%) of colorless crystals, m.
p. 145 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.64 (s, 1H), 8.31
(d, J = 8.4 Hz, 1H), 8.07 (dd, J = 7.9/1.6 Hz, 1H), 8.00 (dd, J =
9.1/1.4 Hz, 1H), 7.95–7.89 (m, 2H), 7.82 (ddd, J = 7.9/7.7/1.4
Hz, 1H), 7.65 (ddd, J = 8.6/7.0/0.6 Hz, 1H), 7.40 (dd, J = 8.6/0.8
Hz, 1H), 4.15 (s, 3H) ppm. 13C NMR (100 MHz, DMSO-d6): δ =
140.8, 136.1, 135.0, 134.6, 133.0, 132.3, 131.4, 129.7, 127.8,
125.8, 123.8, 119.1, 110.7, 38.2 ppm. IR (ATR): 3143, 1630,
1540, 1482, 1436, 1381, 1265, 1214, 1158, 998, 817, 757,
553 cm−1. ESI-MS (0 V): m/z = 243.1 [M+]. HR-ESI-MS:
C14H12N2Cl required 243.0689. Found: 243.0692.
5-Bromo-1-(4-iodophenyl)-2-methyl-1H-indazolium hexa-
fluorophosphate 12d. Yield: 524 mg (94%) of colorless crys-
tals, m.p. 195 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.50 (s,
1H), 8.58 (dd, J = 1.8/0.5 Hz, 1H), 8.20–8.17 (m, 2H), 7.96 (dd,
J = 9.1/1.8 Hz, 1H), 7.63–7.59 (m, 2H), 7.44 (d, J = 9.1 Hz, 1H),
4.16 (s, 3H) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 139.6,
139.3, 136.7, 134.5, 131.0, 130.1, 125.5, 120.6, 117.6, 113.3,
100.5, 38.7 ppm. IR (KBr): 3139, 1624, 1536, 1494, 1448, 1246,
1211, 1172, 1052, 1006, 931, 840, 558 cm−1. ESI-MS (0 V): m/z =
413 [M+]. HR-ESI-MS: C14H11N2BrI required 412.9150. Found:
412.9152.
1-(4-Iodophenyl)-2-methyl-1H-indazolium hexafluoro-
phosphate 12e. Yield: 418 mg (87%) of colorless crystals, m.
p. 147 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.52 (s, 1H), 8.26
(dd, J = 8.6/0.8 Hz, 1H), 8.20–8.17 (m, 2H), 7.88–7.84 (m, 1H),
7.64–7.58 (m, 3H, 2-H), 7.44 (dd, J = 8.6 Hz/0.8 Hz, 1H), 4.15 (s,
3H) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 140.6, 139.5,
135.1, 134.0, 131.0, 130.4, 125.5, 123.3, 119.2, 110.9, 100.2,
38.5 ppm. IR (KBr): 3143, 1628, 1535, 1487, 1169, 1011, 853,
837, 753, 557 cm−1. ESI-MS (0 V): m/z = 335 [M+]. HR-ESI-MS:
C14H12N2I required: 335.0045. Found: 335.0044.
2-Methyl-1-(4-trifluoromethylphenyl)-1H-indazolium hexa-
fluorophosphate 12f. Yield: 351 mg (83%) of colorless crystals,
m.p. 120 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.57 (s, 1H),
8.28 (d, J = 8.4 Hz, 1H), 8.22 (d, J = 8.4 Hz, 2H), 8.11 (d, J =
8.4 Hz, 2H), 7.90–7.86 (m, 1H), 7.65–7.61 (m, 1H), 7.49 (dd,
J = 8.4/0.6 Hz, 1H), 4.20 (s, 3H) ppm. 13C NMR (100 MHz,
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DMSO-d6): δ = 140.7, 135.7, 134.3, 134.2, 132.2 (q, J = 32.4 Hz),
130.4, 127.9 (q, J = 3.7 Hz), 125.7, 123.6 (q, J = 272.9 Hz), 123.5,
119.3, 111.0, 38.8 ppm. IR (KBr): 3120, 1631, 1614, 1538, 1518,
1454, 1326, 1131, 933, 844, 753 cm−1. ESI-MS (0 V): m/z =
277 [M+]. HR-ESI-MS: C15H13N2F3 required 278.1031. Found:
278.1031.
2-Methyl-1-(3,5-dimethylphenyl)-1H-indazolium hexafluoro-
phosphate 12g. Yield: 336 mg (88%) of colorless crystals,
m.p. 149 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.51 (s, 1H), 8.23
(dt, J = 8.4/0.8 Hz, 1H), 7.87–7.83 (m, 1H), 7.61–7.57 (m, 1H),
7.46 (d, J = 0.5 Hz, 1H), 7.43 (s, 2H), 7.39 (dd, J = 8.8/0.7 Hz,
1H), 4.16 (s, 3H), 2.42 (s, 6H) ppm. 13C NMR (100 MHz,
DMSO-d6): δ = 140.6, 140.3, 134.9, 134.0, 133.7, 130.6, 126.3,
125.4, 123.4, 119.2, 111.1, 38.6, 20.8 ppm. IR (KBr): 3145, 1631,
1615, 1594, 1536, 1463, 1245, 1189, 1167, 883, 836, 593,
557 cm−1. ESI-MS (0 V): m/z = 237 [M+]. HR-ESI-MS: C16H18N2
required 238.1470. Found: 238.1471.
5-Bromo-2-methyl-1-phenyl-1H-indazolium hexafluoro-
phosphate 12h. Yield: 161 mg (75%) of colorless crystals, m.p.
170 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.50 (s, 1H),
8.59 (dd, J = 1.8/0.5 Hz, 1H), 7.96 (dd, J = 9.2/1.8 Hz, 1H),
7.85–7.79 (m, 5H), 7.37 (d, J = 9.2 Hz, 1H), 4.16 (s, 3H) ppm.
13C NMR (100 MHz, DMSO-d6): δ = 139.4, 136.8, 134.3,
132.7, 130.7, 130.5, 129.1, 125.5, 120.6, 117.5, 113.3,
38.8 ppm. IR (KBr): 3157, 3141, 3109, 3077, 1535, 1500, 1442,
1242, 1142, 1014, 838, 700, 558 cm−1. ESI-MS (0 V): m/z = 287.0
[M+]. HR-ESI-MS: C14H12N2Br required 287.0184. Found:
287.0185.
2-Ethyl-1-phenyl-1H-indazolium hexafluorophosphate 12i.
Yield: 282 mg (77%) of colorless crystals, m.p. 143 °C. 1H NMR
(400 MHz, DMSO-d6): δ = 9.62 (s, 1H), 8.24 (d, J = 8.3 Hz, 1H),
7.89–7.79 (m, 6H), 7.62 (ddd, J = 8.6/7.0/0.8 Hz, 1H), 7.36 (dd,
J = 8.6/0.8 Hz, 1H), 4.48 (q, J = 7.2 Hz, 2H), 1.45 (t, J = 7.2 Hz,
3H) ppm. 13C NMR (100 MHz, DMSO-d6): δ = 141.0, 134.1,
133.6, 132.5, 130.9, 130.8, 129.1, 125.5, 123.3, 119.2, 110.9,
46.9, 13.7 ppm. IR (KBr): 3148, 3114, 3069, 2991, 2948, 1987,
1632, 1537, 1494, 1447, 1396, 1240, 1158, 883, 835, 759, 691,
558 cm−1. ESI-MS (0 V): m/z = 223.1 [M+]. HR-ESI-MS: C15H16N2
required 224.1313. Found: 224.1310.
1-([1,1′-Biphenyl]-4-yl)-2-methyl-1H-indazolium hexafluoro-
phosphate 12j. Yield: 309 mg (72%) of colorless crystals, m.p.
187 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.55 (s, 1H), 8.28
(d, J = 8.6 Hz, 1H), 7.94–7.92 (m, 2H), 7.90–7.84 (m, 3H),
7.62 (ddd, J = 8.6/7.1/0.6 Hz, 1H), 7.59–7.55 (m, 2H),
7.51–7.46 (m, 2H), 4.21 (s, 3H) ppm. 13C NMR (100 MHz,
DMSO-d6): δ = 143.8, 140.7, 138.3, 134.9, 134.0, 129.8,
129.6, 129.2, 128.7, 128.6, 127.1, 125.4, 123.3, 119.2, 111.0,
38.6 ppm. IR (ATR): 3126, 1627, 1489, 1449, 1360, 1164, 1010,
822, 778, 753, 728, 582, 555 cm−1. ESI-MS (30 V): m/z = 285.1
[M+]. HR-ESI-MS: C20H17N2 required 285.1392. Found:
285.1392.
2-Methyl-1-(3′-methyl-[1,1′-biphenyl]-4-yl)-1H-indazolium
hexafluorophosphate 12k. Yield: 257 mg (58%) of colorless
crystals, m.p. 97 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.55 (s,
1H), 8.28 (d, J = 8.5 Hz, 1H), 8.09 (dd, J = 8.5 Hz, 2H),
7.93–7.86 (m, 3H), 7.66–7.60 (m, 3H), 7.47–7.43 (m, 2H), 7.30
(d, J = 7.5 Hz, 1H), 4.21 (s, 3H), 2.43 (s, 3H) ppm. 13C NMR
(100 MHz, DMSO-d6): δ = 144.0, 140.7, 138.4, 138.2, 134.9,
134.0, 129.7, 129.6, 129.2, 129.1, 128.6, 127.8, 125.4, 124.2,
123.3, 119.2, 111.0, 38.6, 21.1 ppm. IR (ATR): 1629, 1515, 1486,
1360, 1167, 823, 749, 591, 580, 555, 429 cm−1. ESI-MS (30 V):
m/z = 299.1 [M+]. HR-ESI-MS: C21H19N2 required 299.1548.
Found: 299.1548.
General procedure for the rearrangements of 2-alkyl-1-aryl-1H-
indazolium hexafluorophosphates to the acridines 13a–k
A mixture of 1.0 mmol of 2-alkyl-1-aryl-1H-indazolium hexa-
fluorophosphate and 2.0 mmol of K3PO4 in 20 mL of anhy-
drous dioxane or toluene was stirred at reflux temperature
under a nitrogen atmosphere over a period of 3 hours. Then
the resulting mixture was cooled to room temperature and the
solvent was removed in vacuo. The crude product was purified
by flash column chromatography (chloroform–methanol =
3 : 1), dissolved in 20 mL of chloroform, washed with 10 mL of
0.1 M NaOH solution and dried in vacuo.
N-Methylacridin-9-amine 13a. Yield: 181 mg (87%) of a
yellow solid, m.p. 171 °C (170–171 °C, ref. 45). All spectro-
scopic data are identical to those reported.
1-Chloro-N-methylacridin-9-amine 13ba. Yield: 73 mg (30%)
of a yellow solid, m.p. 170 °C. 1H NMR (400 MHz, MeOH-d4):
δ = 7.97 (d, J = 8.3 Hz, 1H), 7.53–7.46 (m, 2H), 7.42–7.35 (m,
2H), 7.18–7.14 (m, 2H), 3.43 (s, 3H) ppm. 13C NMR (100 MHz,
MeOH-d4): δ = 160.6, 143.6, 142.6, 135.5, 134.5, 131.3, 127.9,
126.6, 123.5, 119.2, 118.6, 114.3, 112.4, 37.8 ppm; IR (ATR):
2913, 2845, 1591, 1547, 1514, 1448, 1393, 1339, 922, 751,
646 cm−1. ESI-MS (0 V): m/z = 243.1 [M + H+]. HR-ESI-MS:
C14H12N2Cl required 243.0689. Found: 243.0687.
3-Chloro-N-methylacridin-9-amine 13bb. Yield: 97 mg (40%)
of yellow solid, m.p. 146 °C. 1H NMR (400 MHz, MeOH-d4): δ =
8.18 (dd, J = 8.7/0.6 Hz, 1H), 8.17 (d, J = 9.4 Hz, 1H), 7.72 (dd,
J = 8.7/0.6 Hz, 1H), 7.69 (d, J = 2.1 Hz, 1H), 7.58 (ddd, J = 8.7/
6.6/1.3 Hz, 1H), 7.22 (ddd, J = 8.7/6.6/1.3 Hz, 1H), 7.08 (dd, J =
9.4/2.1 Hz, 1H), 3.46 (s, 3H) ppm. 13C NMR (100 MHz,
MeOH-d4): δ = 154.5, 150.5, 150.3, 137.4, 131.9, 128.0, 127.2,
126.3, 124.8, 123.2, 123.0, 116.1, 114.1, 36.7 ppm; IR (KBr):
2924, 2853, 1633, 1593, 1465, 1383, 842, 558 cm−1. ESI-MS
(0 V): m/z = 243.1 [M + H+]. HR-ESI-MS: C14H12N2Cl required
243.0689. Found: 243.0687.
4-Chloro-N-methylacridin-9-amine 13c. Yield: 200 mg (83%)
of a yellow solid, m.p. 161 °C. 1H NMR (400 MHz, MeOH-d4):
δ = 8.30 (dd, J = 8.8/0.8 Hz, 1H), 8.23 (dd, J = 8.8/1.2 Hz, 1H),
8.03 (dd, J = 8.8/0.8 Hz, 1H), 7.77 (dd, J = 7.2/1.2 Hz, 1H), 7.65
(ddd, J = 8.8/6.6/0.8 Hz, 1H), 7.31 (ddd, J = 8.8/6.6/0.8 Hz, 1H),
δ = 7.18 (dd, J = 8.8/7.2 Hz, 1H), 3.54 (s, 3H) ppm. 13C NMR
(100 MHz, MeOH-d4): δ = 155.3, 150.2, 146.0, 131.8 (2 carbon
signals overlapped), 131.4, 128.6, 125.1, 124.4, 123.5, 121.9,
117.5, 116.5, 37.2 ppm; IR (ATR): 2919, 2849, 1556, 1505, 1456,
1397, 1255, 1118, 882, 859, 760, 731, 660 cm−1. MS (70 eV):
m/z = 242.1 [M+]. HR-ESI-MS: C14H12N2Cl required 243.0689.
Found: 243.0690.
2-Bromo-7-iodo-N-methylacridin-9-amine 13d. Yield: 144 mg
(35%) of a yellow solid, m.p. 191 °C. 1H NMR (600 MHz,
Paper Organic & Biomolecular Chemistry
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MeOH-d4): δ = 8.70 (s, 1H), 8.51 (s, 1H), 7.91 (d, J = 8.9 Hz,
1H), 7.77 (d, J = 9.0 Hz, 1H), 7.67 (d, J = 8.9 Hz, 1H), 7.52 (d, J =
9.0 Hz, 1H), 3.56 (s, 3H) ppm. 13C NMR (150 MHz, MeOH-d4):
δ = 153.4, 146.9, 146.7, 141.0, 135.8, 134.2, 128.5, 128.3, 127.7,
117.4, 116.7, 116.6, 87.0, 36.6 ppm; IR (KBr): 3063, 2924, 2854,
2064, 1581, 1559, 1516, 1470, 1398, 1358, 1260, 951, 821,
736 cm−1. ESI-MS (0 V): m/z = 412.7 [M + H+]. HR-ESI-MS:
C14H11N2BrI required 412.9150. Found: 412.9153.
2-Iodo-N-methylacridin-9-amine 13e. Yield: 137 mg (41%) of
a yellow solid, m.p. 178 °C. 1H NMR (400 MHz, MeOH-d4): δ =
8.71 (d, J = 1.8 Hz, 1H), 8.37 (dd, J = 8.8/0.8 Hz, 1H), 7.88 (dd,
J = 9.0/1.9 Hz, 1H), 7.86 (dd, J = 9.0/0.6 Hz, 1H), 7.72 (ddd, J =
9.0/6.6/1.3 Hz, 1H), 7.60 (d, J = 9.0 Hz, 1H), 7.36 (ddd, J =
9.0/6.6/1.2 Hz, 1H), 3.59 (s, 3H) ppm. 13C NMR (100 MHz,
MeOH-d4): δ = 153.7, 149.8, 148.0, 139.9, 133.8, 132.0,
129.4, 127.7, 125.5, 123.3, 117.9, 116.0, 86.1, 36.8 ppm;
IR (KBr): 2923, 2852, 1620, 1556, 1521, 1459, 1401, 1384,
1260, 1016, 938, 817, 759, 657 cm−1. MS (70 eV): m/z =
334 [M+]. HR-ESI-MS: C14H12N2I required 335.0045. Found:
335.0049.
N-Methyl-2-(trifluoromethyl)acridin-9-amine 13f. Yield:
141 mg (51%) of a yellow solid, m.p. 195 °C (dec.). 1H NMR
(400 MHz, MeOH-d4): δ = 8.77 (s, 1H), 8.49 (dd, J = 8.8/0.8 Hz,
1H), 8.00 (dd, J = 8.8/1.8 Hz, 1H), 7.89 (ddd, J = 8.8/6.8/1.2 Hz,
1H), 7.85 (d, J = 9.2 Hz, 1H), 7.75 (dd, J = 8.4/0.6 Hz, 1H), 7.49
(ddd, J = 9.4/6.8/1.2 Hz, 1H), 3.71 (s, 3H) ppm. 13C NMR
(100 MHz, MeOH-d4): δ = 159.4, 144.2, 143.6, 136.2, 130.6
(q, J = 3.0 Hz), 127.1, 125.6 (q, J = 33 Hz), 125.4 (q, J = 271 Hz),
125.0, 124.7 (q, J = 4.5 Hz), 122.6, 121.4, 114.7, 113.5,
36.8 ppm; IR (KBr): 3236, 2947, 2885, 1646, 1594, 1326,
1161, 1127, 1068, 841, 760, 559 cm−1. MS (70 eV): m/z =
276 [M+]. HR-ESI-MS: C15H12N2F3 required 277.0953. Found:
277.0953.
N,1,3-Trimethylacridin-9-amine 13g. Yield: 137 mg (58%) of
a yellow solid, m.p. 120 °C. 1H NMR (400 MHz, MeOH-d4): δ =
7.95 (dd, J = 8.2/1.1 Hz, 1H), 7.50 (ddd, J = 8.4/6.8/1.4 Hz, 1H),
7.39 (dd, J = 8.2/0.5 Hz, 1H), 7.14 (ddd, J = 8.4/6.8/1.1 Hz, 1H),
7.02 (s, 1H), 6.86 (s, 1H), 3.43 (s, 3H), 2.64 (s, 3H), 2.36 (s, 3H)
ppm. 13C NMR (100 MHz, MeOH-d4): δ = 160.9, 144.5, 144.1,
142.1, 136.9, 132.4, 132.1, 129.9, 127.7, 127.6, 121.0, 119.0,
116.3, 39.2, 21.7, 21.6 ppm; IR (KBr): 3367, 3144, 2924, 1632,
1595, 1537, 1462, 1154, 839, 759, 557 cm−1; HR-ESI-MS:
C16H17N2 required 237.1392. Found: 237.1391.
2-Bromo-N-methylacridin-9-amine 13h. Yield: 92 mg (32%)
of a yellow solid, m.p. 156 °C. 1H NMR (400 MHz, MeOH-d4):
δ = 8.54 (d, J = 2.0 Hz, 1H), 8.44 (d, J = 8.8 Hz, 1H), 7.87–7.81
(m, 2H), 7.75 (d, J = 8.8 Hz, 1H), 7.66 (d, J = 9.2 Hz, 1H), 7.45
(ddd, J = 8.8/6.8/1.1 Hz, 1H), 3.66 (s, 3H) ppm. 13C NMR
(100 MHz, MeOH-d4): δ = 157.0, 144.7, 142.8, 137.4, 134.9,
127.9, 126.6, 124.6, 124.4, 122.8, 116.9, 116.0, 114.6, 36.7 ppm;
IR (KBr): 2927, 2899, 2321, 2166, 2108, 2081, 1633, 1589, 1556,
1545, 1471, 1174, 1161, 859, 846, 821, 758 cm−1. ESI-MS (0 V):
m/z = 287.0 [M + H+]. HR-ESI-MS: C14H12N2Br required
287.0184. Found: 287.0182.
N-Methyl-2-phenylacridin-9-amine 13j. Yield: 170 mg (83%)
of a yellow solid, m.p. 173 °C. 1H NMR (400 MHz, MeOH-d4):
δ = 8.46 (d, J = 1.6 Hz, 1H), 8.31 (dd, J = 8.7/0.6 Hz, 1H),
7.93–7.88 (m, 2H), 7.82 (dd, J = 8.7/0.6 Hz, 1H), 7.74–7.72 (m,
2H), 7.62 (ddd, J = 8.7/6.6/1.2 Hz, 1H), 7.48–7.44 (m, 2H),
7.36–7.32 (m, 1H), 7.27 (ddd, J = 8.8/6.6/1.2 Hz, 1H), 3.57 (s,
3H, NHMe-H) ppm. 13C NMR (100 MHz, MeOH-d4): δ = 154.9,
149.7, 148.7, 141.9, 135.9, 131.7, 131.2, 130.0, 128.4, 128.3,
128.0, 127.7, 125.4, 123.0, 122.3, 116.2, 116.1, 37.0 ppm; IR
(ATR): 3225, 3055, 1612, 1557, 1519, 1499, 1452, 1397, 1381,
1265, 825, 748, 692, 668, 643 cm−1. MS (70 eV): m/z = 284.1
[M+]. HR-ESI-MS: C20H17N2 required 285.1392. Found:
285.1391.
N-Methyl-2-(m-tolyl)-acridin-9-amine 13k. Yield: 110 mg
(37%) of a yellow solid, m.p. 119 °C. 1H NMR (400 MHz,
MeOH-d4): δ = 8.52 (d, J = 1.7 Hz, 1H), 8.39 (dd, J = 8.8/0.7 Hz,
1H), 7.97 (dd, J = 9.0/1.9 Hz, 1H), 7.91–7.89 (m, 1H), 7.85 (d,
J = 8.6 Hz, 1H), 7.66 (ddd, J = 8.6/6.6/1.2 Hz, 1H), 7.60 (s, 1H),
7.55 (d, J = 8.6 Hz, 1H), 7.38–7.30 (m, 2H), 7.19 (d, J = 7.4 Hz,
1H), 3.63 (s, 3H, NHMe-H), 2.44 (s, 3H, PhMe-H) ppm.
13C NMR (100 MHz, MeOH-d4): δ = 155.0, 149.5, 148.5, 141.8,
139.7, 136.1, 131.7, 131.3, 129.9, 129.1, 128.7, 128.0, 127.6,
125.5, 125.2, 122.9, 122.2, 116.2, 116.1, 37.0, 21.7 ppm; IR
(ATR): 2847, 2805, 1637, 1572, 1491, 1475, 1446, 1389, 1356,
1167, 832, 703 cm−1. MS (70 eV): m/z = 298.2 [M+]. HR-ESI-MS:
C21H19N2 required 299.1548. Found: 299.1544.
2-Phenyl-2H-indazole 16. A mixture of 2.5 mmol of 1H-inda-
zole, 2.0 mmol of 2-(trimethylsilyl)phenyl-trifluoromethanesul-
fonate, 3.0 mmol of NaF and 5.0 mmol of CsF in 15 mL of
acetonitrile was stirred at room temperature under a nitrogen
atmosphere for 24 hours. The resulting mixture was then evap-
orated to dryness. The crude product was purified by flash
column chromatography (petroleum ether–ethyl acetate =
8 : 1). Yield: 198 mg (51%) of colorless crystals. All spectro-
scopic data are identical to those reported.44
1-Methyl-2-phenyl-2H-indazolium tetraphenylborate 17. The
methylation was carried out according to the method
described above. Sodium tetraphenylborate was used for
anion-exchange. Yield: 350 mg (66%) of colorless crystals, m.
p. 192 °C. 1H NMR (400 MHz, DMSO-d6): δ = 9.53 (s, 1H), 8.17
(d, J = 8.5 Hz, 1H), 8.12 (d, J = 8.8 Hz, 1H), 7.97–8.01 (m, 1H),
7.87–7.89 (m, 2H), 7.75–7.85 (m, 3H), 7.59–7.63 (m, 1H),
7.17–7.21 (m, 8H), 6.93 (dd, J = 7.8/7.2 Hz, 8H), 6.79 (t, J = 7.2
Hz, 4H), 4.02 (s, 3H) ppm. 13C NMR (100 MHz, DMSO-d6): δ =
163.4 (q, J = 49 Hz), 140.8, 135.5, 134.1 (q, J = 34 Hz), 133.0,
132.6 (q, J = 21 Hz), 130.1, 127.7, 126.6, 125.5, 125.3 (q, J =
3 Hz), 123.2, 121.5, 119.3, 111.7, 34.4 ppm. IR (KBr): 3090,
3053, 1629, 1579, 1526, 1479, 1244, 1190, 741, 707, 613 cm−1.
ESI-MS (0 V): m/z = 209.1 [M+]. HR-ESI-MS: C14H13N2 required
209.1079. Found: 209.1081.
1-Methyl-2-phenyl-1H-indazole-3(2H)-thione 18. A mixture
of 1.0 mmol of l-methyl-2-phenyl-2H-indazolium tetraphenyl-
borate, 5.0 mmol sulfur and 5.0 mmol of potassium tert-buto-
xide in 20 mL of anhydrous dioxane was stirred at reflux
temperature under a nitrogen atmosphere over a period of
2 hours. Then the resulting mixture was cooled to room temp-
erature and the solvent was removed in vacuo. The crude
product was finally purified by flash column chromatography
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(petroleum ether–ethyl acetate = 1 : 1). Yield: 80 mg (33%) of a
yellow solid, m.p. 140 °C. 1H NMR (400 MHz, CDCl3): δ = 8.15
(d, J = 8.0 Hz, 1H), 7.67–7.56 (m, 5H), 7.52–7.48 (m, 1H),
7.32–7.29 (m, 2H), 3.32 (s, 3H) ppm. 13C NMR (100 MHz,
CDCl3): 175.1, 146.5, 134.8, 132.7, 129.5, 129.4, 128.0, 127.9,
125.9, 123.4, 110.8, 37.4 ppm. IR (KBr): 2923, 2361, 1611, 1591,
1487, 1457, 1342, 1322, 1306, 1156, 1126, 1108, 971, 755,
696 cm−1. MS (70 eV): m/z = 240.1 [M+]. HR-ESI-MS: C14H13N2S
required: 241.0799. Found: 241.0802.
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